drugset / Trial / NCT06106971

Balloon-occluded Retrograde Transvenous Obliteration for Gastric Variceal Rebleeding

NCT06106971

Phase 3 Unknown 68 enrolled Kaohsiung Veterans General Hospital.
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this randomized controlled trial is to compare the rebleeding rate in cirhotic patients with gastric variceal bleeding receiving balloon-occluded retrograde transvenous obliteration and endoscopic tissue glue injection. The main questions it aims to answer are: * Recurrent gastric variceal bleeding * Further decompensation of liver cirrhosis Participants will receive balloon-occluded retrograde transvenous obliteration and endoscopic tissue glue injection. Researchers will compare balloon-occluded retrograde transvenous obliteration and endoscopic tissue glue injection to see if the rebleeding rate associated with balloon-occluded retrograde transvenous obliteration is lower than that associated with endoscopic tissue glue injection.

Timeline

Start
2018-06-28
Primary completion
2025-06
Completion
2025-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator N-butyl-2-cyanoacrylate Other / unclassified Other
Subject Sodium Tetradecyl Sulfate Unknown 3 %